HOME OUR TEAM TRANSACTIONS WHAT WE DO OUR APPROACH CONTACT Investment Banking Advisory to the Life Science Industry Aquilo Partners understands the risks and rewards associated with life science innovation. We have spent our careers providing transaction advice in this sector, and as a result, we understand the development, regulatory and commercial risks that companies must navigate. We also understand how to position, value and capture upside, which is crucial to structuring and closing successful transactions. Our approach to strategic transactions and private placement fundraisings reflects our intimate knowledge of the life science industry and all of the options companies have in responding to inflection points. Aquilo Partners works closely with each client, leveraging our capabilities and extensive network with the needs of our clients. Aquilo’s Life Science Transaction Expertise PRIVATE PLACEMENT & STRATEGIC ADVISORY Aquilo helps select private clients to raise capital, leveraging our proprietary relationships at venture capital, hedge funds, private equity and strategic investors PARTNERING Aquilo is a leader in structuring and negotiating licensing deals across all stages of development, where the expertise to advise on economic and non-economic terms of risk-sharing is critical SELL SIDE Aquilo utilizes our analytical and industry expertise to initiate, structure and negotiate transactions, returning value upfront to shareholders and de-risking future payments M&A Aquilo’s leadership and insight into the M&A process allow us work with acquirors to get transactions completed at attractive valuations M&A Sell-side Aquilo Partners invests significant time getting to know our clients’ stories, enabling us to present compelling and tailored rationale to each potential buyer. The strategic focus of buyers may change, key decisions makers may leave and internal programs often compete for resources – being intimately familiar with these dynamics is one way that Aquilo Partners is able to create value for our clients. Acquisition by Becton Dickinson $75,000,000 Acquisition by Boston Scientific $250,000,000 Acquisition by Actelion $320,000,000 Acquisition of Zoladex in US, CAN from AstraZeneca $476,000,000 Acquisition of Performance Optics $337,500,000+ Purchase of SPL Buy-side Whether it is a targeted transaction or a comprehensive search for acquisition targets, Aquilo Partners aids our clients by providing thoughtful and relevant advice throughout the deal process. We understand the importance of analysis and internal committees for buyers. Aquilo provides comprehensive advisory across all phases of the deal – from identification of targets, to negotiation of terms, to modeling and integration analysis – enabling our buy-side clients to make the right decisions. Private Placement & Strategic Advisory Aquilo Partners tailors each financing outreach to the needs of the client’s management and shareholders – because every situation is unique and not all investors are created equal. Our process enables management to maintain its focus on execution and creating credible alternatives forward – essential elements to maintaining leverage in a financing process. $275,000,000 Series A Financing Strategic Advisor to Nuvation Bio $45,000,000 Series C Preferred Stock Partnering $252,000,000+ Ex-US Partnership with Santen Strategic Investment and Partnership with IQVIA $765,000,000 Partnership with Astellas Aquilo is a leader in structuring and negotiating licensing deals across all stages of development, where the expertise to advise on economic and non-economic terms of risk-sharing is critical Member FINRA / SIPC LOCATIONS San Francisco 601 California Street, 5th Floor San Francisco, CA 94108 (415) 677-9773 info@aquilopartners.com New York 888 Seventh Avenue, 12th Floor New York, NY 10106 (415) 505-2748 info@aquilopartners.com Boston 101 Main Street, 14th Floor Cambridge, MA 02142 (617) 401-2483 info@aquilopartners.com CONTACT US (415) 677-9773 info@aquilopartners.com SITE MAP Home Our Team Transactions What We Do Our Approach Disclosure Contact Aquilo Partners, L.P. © 2001-2020. All Rights Reserved.